Big news from Merlin Therapeutics: We’re excited to welcome Dr. Nora Yang as the new CEO! 🎉 With her leadership, Merlin Therapeutics will continue to push forward critical NF2 gene therapies. Read more here: merlintherapeutics.com/newsroom/merli…

More people are affected by rare diseases than cancer, yet they receive less funding. This gap leaves millions awaiting breakthroughs. We aim to close this gap by supporting research like the Antibody Project at Yale. Support us today to bridge this gap: buff.ly/41o0LsS

At NF2 BioSolutions, we're committed to finding a cure for Amelia and all NF2 fighters. With initiatives like the Antibody Project at Yale, we aim to offer hope and new treatments. Your support can turn "What If" into reality. Donate Now: buff.ly/41o0LsS

We are incredibly moved by the generosity and dedication of our Chinese ambassadors at the Shenzhen Neurofibromatosis Care Center of China (NFCC); they have raised $3,236.65 for our Giving Tuesday campaign to support the antibodies project at Yale. Thank you!!

China 🇨🇳: Clinical trial of NF2 gene therapy begins today. Looking forward to great results. #endNF2 【ST002 gene therapy for neurofibromatosis type 2 (NF2)】 clinicaltrials.gov/study/NCT06834…

To learn more about our efforts and join us in the fight against NF2, please visit our website at nf2biosolutions.org To donate, please click here: buff.ly/h5OqMv8

We’re thrilled to host Dr. Bae-Hoon Kim from PRG Science & Technology 🇰🇷 in a special webinar. Dr. Kim will share the latest on a new inhibitor drug trial for NF2 currently underway in Korea. Click here to register: buff.ly/x0R5aYi

Missed the Webinar? We were honored to host Dr. Bae-Hoon Kim, Ph.D., from PRG Science & Technology (Korea), in an insightful session on a new inhibitor drug trial for NF2 that is currently in progress. Watch the full recording now on YouTube: 🔗 buff.ly/QWipMPQ

🎥 Missed the live webinar? The recording is now available! Learn about a groundbreaking AAV9-based gene therapy approach to treat NF2, presented by leading researchers in the field. ▶️ Watch the full recording now: 🔗 buff.ly/RqYqfJc

In May 2025, at the "NF Best Practices Summit" held in Barcelona, ​​NFCC Project Department volunteer Deanna shared NFCC's practical experience in patient support and holding MDT free clinics online. youtu.be/vZ5NSKqegDQ?si… #endNF

The Geoffrey Jefferson Brain Research Centre in Manchester has secured a £700,000 grant to accelerate NF2 research, funding studies into the mechanisms of brain tumours and inflammation pathways in vestibular schwannomas and related tumours. Article here: buff.ly/TPsAMlj

We’ve come a long way, and the NF2 community made it possible. We are now doing Safety Studies, funded by a competitive $700,000 NIH award. The next milestone: fund manufacturing. Donate today: Donate from the US: buff.ly/rTTfNEn

The NF2 patient community at the Neurofibromatosis Shenzhen Care Center in China came together this Giving Tuesday to raise $2,554 in support of NF2 BioSolutions. We are grateful for your generosity and support. Thank you for standing with us and helping advance NF2 research.